Trial intelligence / Profile preview

Desmopressin for prevention of bleeding after kidney biopsy

IRCT20090701002112N3Phase 2Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Jun 2018
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in Bleeding complications comparing Desmopressin acetate with Placebo (2 arms). Primary endpoints: Bleeding complications after kidney biopsy and Post-biopsy hematoma detected by ultrasound. Started Jun 2018; status: completed.

02

Drugs

desmopressin
03

Conditions

Bleeding complications

Beyond the preview

Go deeper on IRCT20090701002112N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20090701002112N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call